Arkolith/Insider Trading/ALLO/Form 4

Roberts Zachary

President and CEOAllogene Therapeutics, Inc. (ALLO) · full profile →Form 4 · filed Jul 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Grant(A)135K—$0135K
Jul 1, 2026Grant(A)476K—$0476K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001851044-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML